Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Pediatric nephrology (Berlin, West)

• Publication date

  2004-01-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00467-003-1364-1PMID 14745634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Darbepoetin Alfa: A Novel Erythropoiesis-Stimulating Protein

  2002cited by this paper
• [Treatment of anemia in chronic renal failure by a long-activing activator of erythropoiesis].

  2002cited by this paper
• Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease

  2002influential reference
• Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.

  2002cited by this paper
• Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

  2002cited by this paper
• Effect of a High‐Fat Meal on the Pharmacokinetics of the Des‐F(6)‐Quinolone BMS‐284756

  2002cited by this paper
• Dose Conversion from Recombinant Human Erythropoietin to Darbepoetin alfa: Recommendations From Clinical Studies

  2002cited by this paper
• Antibodies against rHuEPO: native and recombinant.

  2002cited by this paper
• Novel erythropoiesis stimulating protein for managing the anemia of chronic kidney disease.

  2001cited by this paper
• The clinical potential of novel erythropoiesis stimulating protein

  2001cited by this paper
• Novel erythropoiesis stimulating protein.

  2000cited by this paper
• Calculated and measured oxygen consumption in mechanically ventilated surgical patients in the early post-operative period.

  1999cited by this paper
• Natural logarithmic estimates of Kt/V in the pediatric hemodialysis population.

  1999cited by this paper
• NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative.

  1997cited by this paper
• Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn.

  1995cited by this paper
• Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis.

  1990cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.

  1987cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.

  1987cited by this paper
• Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

  1986cited by this paper
• The role of carbohydrate in erythropoietin action.

  1985cited by this paper

• Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review

  2022cites this paper
• Comparison of darbepoetin alpha and recombinant human erythropoietin for treatment of anemia in pediatric chronic kidney disease: a non-inferiority trial from India

  2022cites this paper
• How Near Are We to Using Darbepoetin or Erythropoietin as Neuroprotective Agents for Perinatal Hypoxic-Ischemic Encephalopathy?

  2019cites this paper
• Darbepoetin Alfa in Young Infants With Renal Failure: Single Center Experience, a Case Series and Review of the Literature

  2018cites this paper
• Hemodialysis in Adolescents

  2018cites this paper
• USE OF DARBEPOETIN ALFA (ARANESP®) FOR ANEMIA TREATMENT IN CHILDREN WITH CHRONIC KIDNEY DISEASE – CLINICAL EXPERIENCE OF BULGARIAN PEDIATRIC GROUP

  2017cites this paper
• 2015 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

  2017cites this paper
• Chapter 88 – Management of Anemia in Children Undergoing Dialysis

  2017cites this paper
• Charting a course for erythropoietin in traumatic brain injury.

  2016cites this paper
• Regeneration in the nervous system with erythropoietin.

  2016cites this paper
• Regeneration in the nervous system with erythropoietin.

  2016cites this paper
• Anemia in Chronic Renal Disease

  2016cites this paper
• Erythropoietin and diabetes mellitus.

  2015cites this paper
• [Recommendations for anemia treatment in pediatric patients].

  2014cites this paper
• Management of anemia with erythropoietic-stimulating agents in children with chronic kidney disease

  2014cites this paper
• Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan

  2013cites this paper
• Comparison of recombinant human erythropoietin and darbepoetin alpha in children

  2013cites this paper
• Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan

  2013cites this paper
• Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease

  2012cites this paper
• Disposition and interaction of biotherapeutics in pediatric populations.

  2012cites this paper
• Darbepoetin Alfa

  2012cites this paper
• Dose optimization and body size

  2011cites this paper
• Continuous EPO receptor activator therapy of anemia in children under peritoneal dialysis

  2011influential citation
• Pediatric Dosing and Body Size in Biotherapeutics

  2010cites this paper
• 2008 Japanese Society for Dialysis Therapy: Guidelines for Renal Anemia in Chronic Kidney Disease

  2010cites this paper
• Chapter 17 – The Pediatric Patient with Chronic Kidney Disease

  2010cites this paper
• Current controversies in the management of the anemia of prematurity.

  2009cites this paper
• Peritoneal Dialysis in Children

  2009cites this paper
• Intravenous Iron Supplementation in Korean Children on Chronic Dialysis

  2009cites this paper
• Darbepoietin alpha: pharmacokinetics and clinical use in neonates

  2009cites this paper
• CHAPTER 49 – Anemia in Chronic Renal Disease

  2008cites this paper
• 2008年版 日本透析医学会「慢性腎臓病患者における腎性貧血治療のガイドライン」

  2008cites this paper
• Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure

  2007cites this paper
• Anemia in children with chronic kidney disease

  2007cites this paper
• Erythropoetin in der pädiatrischen Nephrologie

  2007cites this paper
• Intraperitoneal treatment with darbepoetin for children on peritoneal dialysis

  2007cites this paper
• Iron therapy for renal anemia: how much needed, how much harmful?

  2007cites this paper
• Delayed erythropoietin therapy reduces post-MI cardiac remodeling only at a dose that mobilizes endothelial progenitor cells.

  2007cites this paper
• Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease

  2006cites this paper
• Intravenous administration of darbepoetin to NICU patients

  2006cites this paper
• Overview of the management of chronic kidney disease in children

  2006cites this paper
• Opinion: How Should Chronic Medical Therapies be Altered with the Onset of End‐Stage Renal Disease and Initiation of Dialysis?

  2006cites this paper
• The use of darbepoetin in infants with chronic renal impairment

  2006cites this paper
• Opinion: How Should Chronic Medical Therapies be Altered with the Onset of End‐Stage Renal Disease and Initiation of Dialysis?

  2006cites this paper
• Single-Dose Darbepoetin Administration to Anemic Preterm Neonates

  2005cites this paper
• Darbepoetin alfa (Aranesp™) in children with chronic renal failure

  2005cites this paper
• Anemia in children with chronic kidney disease.

  2005cites this paper
• Sodium ferric gluconate complex therapy in anemic children on hemodialysis

  2005cites this paper
• Chapter 14 – The Pediatric Patient with Chronic Kidney Disease

  2005cites this paper
• Darbepoetin alfa (Aranesp TM )i nchildren with chronic renal failure

  2005cites this paper
• Report of an NIH task force on research priorities in chronic kidney disease in children

  2005cites this paper
• Long-acting erythropoietin: clinical studies and potential uses in neonates.

  2004cites this paper